The effects of adding intrathecal midazolam to bupivacaine in spinal anesthesia by عیسی زاده فر, خاطره et al.
_____________________________________________________________________________________________________ 
 
*Corresponding author: E-mail: m.entezari@arums.ac.ir; 
Email: isazadehfar@yahoo.com; 
 
 
Journal of Advances in Medicine and Medical Research 
 
24(8): 1-7, 2017; Article no.JAMMR.36316 
ISSN: 2456-8899  
(Past name: British Journal of Medicine and Medical Research, Past ISSN: 2231-0614,  
NLM ID: 101570965) 
 
 
The Effects of Adding Intrathecal Midazolam to 
Bupivacaine in Spinal Anesthesia 
 
Khatereh Isazadehfar1, Masood Entezariasl2* and Zahra Aliakbari3 
 
1Department of Community and Preventive Medicine, Ardabil University of Medical Sciences, Ardabil, 
Iran. 
2Department of Anesthesiology, Ardabil University of Medical Sciences, Ardabil, Iran.  
3School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. 
 
Authors’ contributions 
 
This work was carried out in collaboration between three authors. Author KI was responsible for 
analysis and interpretation of data, drafting the article are making critical revisions related to 
important intellectual content of the manuscript, final approval of the version of the article to be 
published. Author ME was responsible for substantial contributions to conception and design of the 
study, acquisition of data, drafting the article are making critical revisions related to important 
intellectual content of the manuscript, final approval of the version of the article to be published. 
Author ZA was responsible for substantial contributions to conception and design of the study, 
drafting the article are making critical revisions related to important intellectual content of the 
manuscript, final approval of the version of the article to be published. 
 
Article Information 
 
DOI: 10.9734/JAMMR/2017/36316 
Editor(s): 
(1) Rakesh Garg, Department of Anaesthesiology, Intensive Care, Pain and Palliative Care, Dr BRAIRCH, All India Institute of 
Medical Sciences, New Delhi, India.  
(2) Georgios Tsoulfas, Assistant Professor of Surgery, Aristoteleion University of Thessaloniki, Thessaloniki, Greece. 
Reviewers: 
(1) Joseph Eldor, Theoretical Medicine Institute, Israel.  
(2) Joe Liu, Washington State University, USA. 
Complete Peer review History: http://www.sciencedomain.org/review-history/22038 
 
 
 
Received 23rd August 2017 
Accepted 23rd September 2017 
Published 24th November 2017 
 
 
ABSTRACT 
 
Aim: To study of intrathecal bupivacaine with and without midazolam to assess its effect on the 
onset, duration of sensory and motor block in lower limb surgery.  
Place and Duration of Study: Fatemi Hospital, Ardebil University of Medical sciences, Iran. From 
March until September 2014.  
Methodology: Eighty patients were randomly allocated to two groups: 40 patients in the control 
group received 3 ml of 0.5% bupivacaine plus 0.4 ml of 0.9% saline intrathecally; 40 patients in the 
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midazolam group received 3 ml of 0.5% bupivacaine plus 0.4 ml (2 mg) midazolam. The onset, 
duration of sensory/motor block, side effects, sedation score and time for request for first rescue 
analgesia were noted in two groups. Data collected by questionnaires and the data were extracted 
and analyzed by SPSS software with Ch-square and T-tests. 
Results: The deference in onset of sensory and motor block between groups was not significant 
(p>0.05). The duration of sensory and motor block was prolonged in the midazolam group 
significantly (p-value =0.005, p-value = 0.014 respectively). There were no episodes of 
hypotension, bradycardia, pruritus, vomiting and urinary retention in any patients. Incidence of 
nausea and sedation score was comparable in the two groups. Sedation score in the Midazolam 
group (3 patient had grade 1 sedation, 35 patients had grade 2 sedation and 2 patients had grade 
3) was slightly higher than control group (1 patient had grade 1 sedation, 32 patients had grade 2 
sedation and 7 patients had grade 3) (p=0.05). Request time for first rescue analgesia (Diclofenac) 
was longer in patients who received midazolam (147.38 versus 215.88, p-value<0.001). 
Conclusion: Intrathecal midazolam increased the duration of sensory and motor block without 
increasing side effects. 
 
 
Keywords: Analgesia; bupivacaine; intrathecal midazolam; sensory block. 
 
1. INTRODUCTION  
 
Compared to general anesthesia, regional 
anesthesia offers numerous opportunities for 
better pain control and patient satisfaction. 
Modern regional anesthesia offers low morbidity 
and mortality rates [1]. Regional Anesthesia 
techniques have had great advances such as the 
reduction of the likelihood of complications; these 
techniques also lead to less bleeding than the 
surgery under GA. Although there are several 
different techniques for RA, spinal anesthesia is 
the easiest and the most economical compared 
to other methods [2]. 
 
Inadequate control of postoperative pain has 
adverse effects on the physiological, metabolic, 
and psychological status of individual [3,4].  
 
To reduce side effects of the technique and 
increase the duration of analgesia as well as its 
faster onset, various additives are used in spinal 
anesthesia [3,4]. Bupivacaine 0.5% is one of the 
local anesthetics that are used in regional 
anesthesia [5]. For improvement of the rapid 
onset; maximize the duration and quality of 
spinal anesthesia many adjuvants such as 
adrenaline, clonidine, midazolam, neostigmine, 
ketamine and opiates have been tried [6].  
 
Although adding opiates to local anesthetics 
improved intraoperative and postoperative 
analgesia provided by 0.5% bupivacaine, it has 
some complications such as delayed respiratory 
depression, nausea, vomiting, urinary retention 
and pruritus [6,7]. Midazolam is a rather short-
acting benzodiazepine, with anxiolytic, sedative, 
anticonvulsant and muscle relaxant effects, 
influencing GABA receptor and influence on 
neurons by entering chloride into them. 
Midazolam is metabolized in the liver and 
excreted in the urine [8,9].  
 
The effects of midazolam are studied in some 
studies, for example in one study adding 
midazolam at various doses only provides faster 
sensory-motor block than bupivacaine [1] and in 
other study the effects of adding midazolam to 
bupivacaine on postoperative pain reduction in 
spinal anesthesia provided more desirable and 
advisable control pain [7]. Another study showed 
that in spinal anesthesia adding midazolam 
significantly increases duration of analgesia (320 
minutes compared to 220 minutes) as well as 
motor block (255 minutes compared to 195 
minutes) and decreases postoperative nausea 
and vomiting (PONV) [10].  
 
In this triple blind clinical trial study we evaluated 
the effects of adding midazolam to bupivacaine 
on the duration of sensory and motor block in 
patients undergoing lower limb orthopedic 
surgery by spinal anesthesia and compare the 
side effects of intrathecal midazolam plus 
bupivacaine and bupivacaine alone. 
 
2. MATERIALS AND METHODS  
 
A triple-blind prospective randomized clinical trial 
(registered at Iranian Registry of Clinical Trials; 
registration code: IRCT2014021716612N1) was 
planned from March until September 2014 on 
patients scheduled for hip fracture  surgery under 
spinal anesthesia at Fatemi Hospital, Ardebil, 
Iran. After obtaining approval from the Ethics 
Committee of Ardebil University of Medical 
Sciences, 80 adult patients, aged 15–80 yr, ASA 
I–II, undergoing lower limb orthopedic surgery, 
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were recruited in this study. Written informed 
consents were obtained from all study 
participants, after describing all aspects of the 
study. Exclusion criteria were loss of 
consciousness, patients with contraindications to 
regional anesthesia, or sensitivity to study drugs. 
Based on existing studies and articles, and in 
particular with regards to the results obtained 
from the study of Shadangi and colleagues, [6] 
40 samples of each group were determined 
considering α = 0.05, p =%80. 
 
Patients were randomly allocated into two groups 
in a triple-blinded manner using a sealed 
envelope. Control group (n = 40) received 3 mL 
0.5% bupivacaine with 0.4 mL saline, while case 
group (n = 40) received 3 mL 0.5% bupivacaine 
and 0.4 mL (2 mg) midazolam (5 mg/mL, 
preservative-free) mixture.  
 
For ensuring blinding, randomly allocated coded 
syringes of drugs were prepared by an 
anesthesiologist who did not perform 
subarachnoid block or record the outcome 
intraoperative and postoperative period. Neither 
the participants, nor the anesthesiologist 
responsible for following the participants, and 
investigators collecting data and assessing the 
outcomes were aware of the intervention 
assignments. 
 
After hydration all patients with Ringer's solution, 
spinal anesthesia was performed intrathecally in 
the sitting position using a 25- gauge needle at 
L4-L5 or L3-L4 in midline approach, under 
aseptic condition. 
 
In case of creating inadequate level of 
anesthesia and anesthesia for surgery, the 
patient was excluded, another patient enrolled in 
the study and another vial was received from 
anesthetic technician of the same group number.  
 
Hemodynamic changes such as pulse oximetry, 
heart rate, respiratory rate, blood pressure and 
cardiac monitoring (ECG) were monitored 
continuously.  
 
These parameters were assessed in this study: 
pain intensity (via the Verbal Numerical Rating, 
zero to 10 scoring method), sedation. Onset of 
sensory block (with the sense of touch and sense 
of pain tests by sterile needle), onset of motor 
block, duration of sensory block, duration of 
motor block. Diclofenac sodium 75 IM was used 
as a rescue analgesic if patient complained of 
pain and requested for analgesia. 
The level of sedation of the patients was 
assessed by the Ramsay sedation score (1: 
anxious, agitated and restlessness, 2: oriented 
and cooperative, 3: responds to command only, 
4: brisk response to loud voice and light glabellar 
tap, 5: sluggish to no response to light glabellar 
tap or loud auditory stimulus, 6: no response 
even to pain).  
 
The level of sensory block was assessed by pin-
prick testing bilaterally along the mid-clavicular 
line. The assessment was performed at 5, 10 
and 15 min after intrathecal injection and then 
every 15 min until regression to the S2 segment. 
Motor block was assessed using a 6-point 
modified Bromage scale (MBS) [11]. These 
measurements were performed at 5, 10 and 15 
min after intrathecal injection and then every 
15min after surgery until no motor blockade 
could be detected 
 
Pruritus, dizziness, nausea, vomiting, urinary 
retention were observed duration of operation 
and in the postoperative period. The request time 
for the first painkiller drug or the patient’s pain 
complaint was recorded on the checklist. 
 
The data was expressed as mean (SD), numbers 
with percentage. Quantitative variables were 
analyzed using Student's independed t-test. 
Categorical data was analyzed using Chi-square 
and Fischer exact test. The Mann-Whitney ‘U’ 
test was used wherever appropriate. Value of 
P<0.05 is considered statistically significant and 
value of P<0.01 is considered high statistically 
significant. An SPSS V.16 package was used for 
statistical analysis. 
 
3. RESULTS AND DISCUSSION 
 
Patient groups did not show differences in age, 
gender, body weight and duration of surgery 
(Table 1). 
 
The onsets of sensory and motor block were 
comparable between the two groups. The 
duration of sensory blockade was prolonged in 
the midazolam group (p=0.005) and the duration 
of motor blockade also was prolonged in this 
group (Table 2).  
 
There were no episodes of hypotension, 
bradycardia, pruritus, vomiting and urinary 
retention in any patients, but the incidence of 
nausea was comparable between two groups 
(Table 3). 
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Table 1. Demographic profiles of the two groups 
 
Demographic Mean ± SD P-value 
 Control group (n=40) Midazolam group (n=40)  
Age (yrs) 49.43±12.59 46.95±20.46 0.517 
Gender (M:F) 27:13 27:13 1 
Weight (Kg) 70.37±7.7 68.77±9.9 0.42 
Height (cm) 167.06±18.44 168.72±10.34 0.65 
Duration of surgery (min) 53.88±7.8 53.45±11.5 0.84 
SD: standerd deviation; M: male; F: female 
 
Table 2. Onset and duration of sensory and motor block in tow groups 
 
Parameter (min) Mean ± SD P-Value 
Control group (n=40) Midazolam group (n=40) 
 
Onset of sensory block 2.9±0.5 3.3±1.5 0.5 
Onset of motor block 4.7±0.6 5.1±1.9 0.94 
Duration of sensory block 95.13±17.7 106.25±28.8 0.005* 
Duration of motor block 85.1±14.9 92.05±25.5 0.014 
*High statistically significant 
 
Table 3. Complications/adverse effects in the two groups 
 
Parameter (min) No (%) P-Value 
Control group (n=40) Midazolam group (n=40)  
Bradycardia 0(0) 0(0)  
Pruritus 0(0) 0(0)  
Hypotension 0(0) 0(0)  
Nausea 3(7.5) 8(20) 0.193 
Vomiting 0(0) 0(0)  
Urinary Retention 0(0) 0(0)  
Sedation    
 
Sedation score in the Midazolam group (3 patient 
had grade 1 sedation, 35 patients had grade 2 
sedation and 2 patients had grade 3) was slightly 
higher than control group (1 patient had grade 1 
sedation, 32 patients had grade 2 sedation and 7 
patients had grade 3) (p=0.05). 
 
Comparing the two group’s patients receiving 
Diclofenac, the time was longer for Midazolam 
group (147.38±31.112 vs. 215.88±49.106), which 
was high statistically significant (p<0.001). 
 
3.1 Discussion 
 
In this study, the effects of adding Midazolam to 
Bupivacaine were investigated based on age, 
sex, weight, and the duration of surgery and in 
none of the four mentioned criteria, the difference 
in the two groups was statistically significant.  
 
In an article by Gupta and colleagues, the effects 
of adding Intrathecal Midazolam to hyperbaric 
Bupivacaine on postoperative pain after 
orthopedic surgery of the lower limbs has been 
studied. At the time of onset of sensory block, 
there was no statistically significant difference 
(p>0.05). The value of p=0.943 for motor block 
onset time was statistically insignificant between 
the two groups [12].  
 
In a study conducted by Malarica Kulkarni and 
his colleagues, discussing the role of intrathecal 
midazolam as an additive to bupivacaine in 
postoperative pain control at the surgery of lower 
abdomen and lower extremities, there was no 
significant differences in assessing the onset 
time of sensory block and the time to reach the 
maximum sensory block (p>0.05) [13]. 
 
In another study conducted by Dr. Indrajit and 
colleagues, analgesic effects of adding 
intrathecal Midazolam to Bupivacaine in the 
surgical resection of the prostate has been 
studied. In this study, there was no obvious 
differences between the two groups in terms of 
sensory block onset (2.37 ± 0.15 minutes in 
group B compared with 2.29 ± 0.12 minutes in 
group BM), It was also shown that there was no 
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significant differences between the two groups in 
terms of the onset time of motor block (p>0.05) 
[14]. Our study also, according to the obtained 
results indicated that there was no significant 
difference between the experimental and the 
control group (p>0.05) in terms of the onset time 
of both sensory and motor block after 
administration of anesthetic drug (Table 2). 
 
In a research by Boussofora M et al. [15] the 
effects of intrathecal Midazolam on postoperative 
analgesia when added to a combination of 
clonidine-bupivacaine was evaluated. The results 
showed that the duration of both sensory and 
motor block was significantly higher in the 
Midazolam group (P>0.05).  
 
In another study by N Bhrati and colleagues, the 
effects of adding Midazolam to Bupivacaine to 
reduce postoperative pain and enhance the 
quality of anesthesia after lower abdominal 
surgery were compared and the results showed 
that the duration of sensory block was longer in 
experimental (intervention) group than the control 
group (218 minutes compared with 165 minutes 
and p>0.001. Moreover, the duration of the    
motor block was higher in the experimental 
(intervention) group than the control group 
(p>0.01) [16]. 
 
In a study conducted by Dr. Indrajit and 
colleagues, the duration of sensory block was 
significantly higher in BM group (p<0.001). 
 
Additionally, the study by Malarica Kulkarni and 
his colleagues as well as other similar studies 
indicated that the duration of sensory block             
was significantly higher in the experimental 
(intervention) group (B) than the control group’s 
(A) (266.36 ± 22.56 minutes in group B 
compared to 187.8 ± 22.92 minutes in group A) 
[13].  
 
In our study, the duration of sensory block in the 
Midazolam group has also been longer and the 
difference in the two groups was statistically 
significant (106.25± 28.643 minutes in the 
Midazolam group compared to 95.13 ± 17.746 in 
the saline group and p=0.005). In addition, the 
difference between the two groups was 
statistically significant in terms of the duration of 
motor block (92.05 ± 25.579 minutes in 
Midazolam group compared to 85.10 ± 14.999 
minutes in saline group and p=0.014).  
 
In a study by Anirban Chattopadhyay and 
colleagues, “the analgesic effects of Bupivacaine 
by itself as well as its combination with 
Midazolam on lower abdominal surgery” were 
compared and it was found that there was no 
significant difference between the two groups in 
terms of the comparison of intraoperative events 
(hypotension, bradycardia, nausea, vomiting and 
respiratory depression) (p>0.05).  
 
Regarding the comparison of postoperative 
events (PONV and respiratory depression), we 
found that the p-value for PONV was equal to 
0.025, which was statistically significant (9 out of 
45 patients in group B, and 2 out of 45 patients in 
BM group had nausea). However, there was no 
significant difference between the two groups in 
terms of respiratory depression (p<0.05) [10]. In 
a study performed by Dr. Indrajit and his 
colleagues there was no significant difference 
between the two groups in terms of 
hemodynamic changes (Sat O2, Bp, PR) 
(p>0.05) [14]. In a study by N Bhrati and 
colleagues, there was no significant difference 
between the two groups in terms of neurological 
and other complications [16]. In addition, in 
another study by Jeshnv Prakash Tople and 
colleagues the effects of adding intrathecal 
Midazolam to Bupivacaine on postoperative pain 
in patients undergoing lower limb orthopedic 
surgery were evaluated. The study results 
proved that there was no significant difference 
between the two groups in terms of side effects 
such as nausea and vomiting, Desaturation, 
neurological complications and urinary retention 
and also in terms of hemodynamic variables 
(p>0.05) [17].  
 
In our study, although the rate of nausea 
incidence (Table 3) was more in the Midazolam 
group than in the control group, but there was no 
significant difference between the two groups 
(p=0.193). Other side effects such as 
bradycardia, pruritus, dizziness, hypotension, 
urinary retention were not seen in none of the 
control and intervention group. 
 
Anirban Chattopadhyay and colleagues 
compared Intraoperative Sedation Score 
between the two groups, and the obtained result 
(p=0.017) was statistically significant [10].  
 
The Ramsy Sedation Score between the two 
groups in our study was equal to p=0.05 and 
although this difference was not significant, the 
Sedation Score (drowsiness) of the intervention 
group was slightly higher than that of the control 
group (2.15 ± 0.427 in Midazolam group 
compared with 1.98 ± 0.357 in the saline group). 
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On the other hand, this insignificant difference 
may be due to small sample size of the study 
case and if increasing the sample size, perhaps 
more significant differences was observed. 
Boassofora M and others has shown in their 
study that there was a significant difference 
between the two groups in terms of the time 
needed to get sedatives after surgery and the 
time is longer in the intervention (experimental) 
group (p<0.05) [15]. In our own study, the time of 
receiving the first analgesic (Diclofenac) after 
surgery was p<0.001. It was statistically 
significant, and this time was longer in the 
intervention group than that of the control             
group.  
 
4. CONCLUSION 
 
The present study found that adding Midazolam 
to Bupivacaine in spinal anesthesia is effective 
on increasing the duration of sensory block and 
therefore it increases the duration of analgesia, 
duration of motor block, Ramsy Sedation Score 
(the drowsiness) and also elongates the time 
required to ask for sedatives after surgical 
operations. 
 
Like most of the studies, this study had also 
some limitations including the duration of the 
patients’ follow-up. If the duration of follow-up 
were longer, results that are more accurate 
would be obtained. Since Midazolam has very 
few undesirable side effects and even in its 
administration by itself, just leads to the least 
respiratory and cardiovascular weakness, it is 
considered relatively safe drug even at high 
doses. Thus, it is recommended in patients who 
are candidates for surgery under prolonged 
spinal anesthesia. Midazolam is offered as an 
additive to the main anesthetic, for intrathecal 
use. 
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